Impaired endothelium-dependent vasodilatation in renal failure in humans.
about
Upper limb exercise for haemodialysis fistula surgeryEffect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.Genetic Regulation of Endothelial Vasomotor FunctionThe vascular endothelium and human diseasesAcute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection.Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure.Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study.NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease.Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal diseaseAscorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension.Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.Peripheral vascular dysfunction in chronic kidney diseaseEvaluation of microvascular reactivity with laser Doppler flowmetry in chronic kidney diseaseEndothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney diseaseBody mass index, mortality, and gender difference in advanced chronic kidney disease.Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.Endothelial dysfunction: cardiovascular risk factors, therapy, and outcomeEndothelial cell dysfunction: can't live with it, how to live without it.Heart rate variability during hemodialysis is an indicator for long-term vascular access survival in uremic patients.Reduced residual renal function is associated with endothelial dysfunction in patients receiving peritoneal dialysis.Relations of measures of endothelial function and kidney disease: the Framingham Heart Study.Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations.Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study.Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.Differential regulation of nitric oxide synthase function in aorta and tail artery from 5/6 nephrectomized rats.Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease.Cerebral oximetry values in dialyzed surgical patients: a comparison between hemodialysis and peritoneal dialysis.The effect of calcineurin inhibitors on endothelial function in renal transplant recipients.Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.THE ROLE OF MITOCHONDRIA DERIVED REACTIVE OXYGEN SPECIES IN MICROVASCULAR DYSFUNCTION IN CHRONIC KIDNEY DISEASE.Maturation of arteriovenous fistula: Analysis of key factors.Changes in endothelial function before and after renal transplantation.Endothelin-1 levels and conduit artery mechanical properties in end-stage renal disease.
P2860
Q24235146-3605B6BA-CE7A-472D-A4A0-F92C7211BA75Q24531203-BAF64062-C390-4DFE-B523-6F336F837CF6Q28073934-0ED0F6F7-BD35-41D2-A17A-029F01039DA6Q28302238-0237E49C-9F14-44C8-A60F-53C259A25213Q30399952-0D2503CA-BB33-48C3-954F-77E77DCF40E4Q31105347-8F101FFC-D52B-4A28-8C2B-CB2016FD6A28Q31120569-7F06C516-A97D-4F27-8E0A-9316ACF920F7Q33764561-AC61419D-A6F3-4542-BED8-7C54CBE9FFB1Q33818722-E9EE0E0E-C239-45FF-B926-5F784D01EEB6Q34008329-409F4E20-3244-442F-BB0F-62A4960982EAQ34506899-124A4AA1-8D2B-4EDF-9997-365E02351460Q34747124-017F55C8-F61D-4AAD-B421-A13E3C37C323Q34782948-373124AE-91CA-4157-B1E8-467CF0F1D65CQ35012914-8C9FFF6B-C432-4B68-B023-28100912816DQ35047495-261DF78A-E8E7-40B3-8DEA-552BDE9AC583Q35189982-A761894E-4E24-4CDC-8B43-186EA69F3876Q35571137-FF5F7EF6-24AD-4365-87C0-E7EC8EBAD00CQ35715691-A8698F07-7E5B-418C-8996-F194A305E102Q36012867-2B83B6E7-7CBA-432C-A449-8BB4898B40A3Q36093993-E7705943-793B-4624-B68A-12A2F11F86BDQ36294102-BA47DAC3-6A5D-4E0E-BA8C-B96ADC5F4D45Q36475601-F02FBFD6-B257-45EA-8701-AB757D3086B0Q37150714-180C657D-785F-4E18-9BF3-89295C55010CQ37324434-74B43B3D-A2C7-4A29-B6EA-025CD75577FCQ38206770-E3DC814F-94E5-43F2-8A51-35788F7FEEA3Q39085572-A6C7E3B2-5684-4BE0-836D-937DF904E6BEQ39243739-2115BDC7-846C-46D0-8229-7FFDA795A867Q42020143-66C5DB17-B8E0-4F19-B868-5F39853BF6A9Q43493575-E57AA46E-D1C2-4511-9EF9-9F11CFD3BF88Q43841702-BA69D089-1DE2-4932-8F5D-44B7D1F81482Q44461522-548B38B5-7ABA-42F6-9A04-D10D2D6D47C8Q45081586-878A0381-685C-476E-8094-919CBCED40E8Q46265555-5C27FE72-7903-4A04-AD8B-75529F07D03AQ47142994-9C36B21C-CB53-4AFD-AB90-09E165C72EA1Q47875079-26CD31A9-02CF-4A44-8516-91F2BAAD3C36Q53870875-24A144E2-C559-4D57-A9E0-F98018F5B32F
P2860
Impaired endothelium-dependent vasodilatation in renal failure in humans.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Impaired endothelium-dependent vasodilatation in renal failure in humans.
@ast
Impaired endothelium-dependent vasodilatation in renal failure in humans.
@en
type
label
Impaired endothelium-dependent vasodilatation in renal failure in humans.
@ast
Impaired endothelium-dependent vasodilatation in renal failure in humans.
@en
prefLabel
Impaired endothelium-dependent vasodilatation in renal failure in humans.
@ast
Impaired endothelium-dependent vasodilatation in renal failure in humans.
@en
P2093
P356
P1476
Impaired endothelium-dependent vasodilatation in renal failure in humans.
@en
P2093
P304
P356
10.1093/NDT/16.2.302
P407
P50
P577
2001-02-01T00:00:00Z